Key result
Targeting endogenous metal ions offers a potential therapeutic strategy to mitigate doxorubicin-induced cardiotoxicity.
Why the study?
Doxorubicin administration is associated with cardiotoxicity, creating an urgent need for strategies to reduce side effects, such as targeting endogenous metal ions.
Endogenous metal ions play a crucial role in the pathogenesis of doxorubicin-induced cardiotoxicity, and targeting their homeostasis offers potential therapeutic strategies to mitigate this adverse effect.
Answers are grounded in this paper and cite their sources.
Supports exploration of metal ion modulation to mitigate doxorubicin cardiotoxicity; leaves open whether this improves clinical outcomes.
Doxorubicin is a widely used anticancer drug in clinical practice for the treatment of various human tumors. However, its administration is associated with cardiotoxicity. Administration of doxorubicin with low side effects for cancer treatment and prevention are, accordingly, urgently required. The human body harbors various endogenous metal ions that exert substantial influences. Consequently, extensive research has been conducted over several decades to investigate the potential of targeting endogenous metal ions to mitigate doxorubicin's side effects and impede tumor progression. In recent years, there has been a growing body of research indicating the potential efficacy of metal ion-associated therapeutic strategies in inhibiting doxorubicin-induced cardiotoxicity (DIC). These strategies offer a combination of favorable safety profiles and potential clinical utility. Alterations in intracellular levels of metal ions have been found to either facilitate or mitigate the development of DIC. For instance, ferroptosis, a cellular death mechanism, and metal ions such as copper, zinc, and calcium have been identified as significant contributors to DIC. This understanding can contribute to advancements in cancer treatment and provide valuable insights for mitigating the cardiotoxic effects of other therapeutic drugs. Furthermore, potential therapeutic strategies have been investigated to alleviate DIC in clinical settings. The ultimate goal is to improve the efficacy and safety of Dox and offer valuable insights for future research in this field.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2023) conducted a review in Doxorubicin-induced cardiotoxicity. Metal ion-associated therapeutic strategies was evaluated. Targeting endogenous metal ions such as iron, copper, zinc, and calcium offers potential therapeutic strategies to mitigate doxorubicin-induced cardiotoxicity.
Synapse has enriched 10 related papers. Consider them for comparative context: